Gabapentin 01
Chemical structure diagram of Gabapentin, illustrating the molecular arrangement of its atoms as seen in the image provided.*
Gabapentin Capsule
Product Images NDC 69367-133
8 FDA label images from Westminster Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 69367-133). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Gabapentin 02
A line graph depicting the effect of Gabapentin 3600 mg/day versus placebo on mean pain score over an 8-week period, including a 4-week dose titration period followed by a 4-week fixed dose period. The graph shows mean pain scores on the vertical axis and weeks on the horizontal axis, with Gabapentin showing a decreasing pain score trend compared to placebo.*
Gabapentin 03
Line graph showing mean pain score over a 7-week period comparing placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The graph includes a 3-week dose titration period followed by a 4-week fixed dose period, with pain scores decreasing over time for Gabapentin doses compared to placebo.*
Gabapentin 04
A bar chart titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares placebo (PBO) with gabapentin (GBP) doses in two studies, showing higher response rates for gabapentin groups (29% and 32-34%) versus placebo (12% and 14%). Statistical significance is indicated with p-values <0.01 and <0.001.*
Gabapentin 05
A scatter plot comparing percentage difference versus daily dose (mg) for Gabapentin across three studies labeled as STUDY a, STUDY b, and STUDY c. The x-axis shows daily doses at 600 mg, 900 mg, 1200 mg, and 1800 mg, while the y-axis represents the percentage difference ranging from 2% to 22%. Different markers and colors distinguish the individual studies' data points.*
Gabapentin 06
Label for Gabapentin Capsules USP 100 mg by Westminster Pharmaceuticals, LLC. The label indicates a package of 500 capsules with storage instructions and an NDC number 69367-131-06. Manufactured by ScieGen Pharmaceuticals, Inc. and made in the USA. The label includes a barcode and a Pharmacist medication guide note.*
Gabapentin 07
Label for Gabapentin Capsules USP 400 mg by Westminster Pharmaceuticals, LLC. The label states the package contains 500 capsules. It includes storage instructions, a barcode, NDC 69367-133-06, and manufacturing information indicating ScieGen Pharmaceuticals, Inc. as the manufacturer and Westminster Pharmaceuticals as the labeler.*
Gabapentin 08
Gabapentin Capsules, USP 300 mg oral capsules, package containing 500 capsules. The label indicates prescription-only status and storage instructions. Manufactured by ScieGen Pharmaceuticals and labeled for Westminster Pharmaceuticals, LLC. The label includes a barcode and instructions to dispense in a child-resistant container.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
